In 1969, apt. Drs. Rudy Soetikno, a young pharmacist serving in the Indonesian Army, noted the scarce supply of medicine around him. To alleviate this situation, he decided to utilise his knowledge of medicine, setting up a small pharmacy with friends to produce tablets. This small pharmacy rapidly acquired a reputation for producing highly effective prescription drugs, facilitating its expansion into other pharmaceuticals, facilities, and markets. By 1978, its products were available across all parts of Indonesia. Its name, “Dexa”, was derived from the Greek word for ten, a symbol of perfection.
Thus began Dexa Group, now among Southeast Asia’s largest pharmaceutical providers and a key strategic asset for Indonesia. The group applies its expertise in discovery, formulation, manufacturing, and marketing to supply highly sophisticated pharmaceuticals, nutraceuticals, supplements, and herbal medicines throughout Southeast Asia. It still maintains its trademark relentless emphasis on producing medicines of the highest quality. In fact, Dexa Group also works closely with the Indonesian Pharmaceutical Association to improve compliance standards across the entire industry.
Vision & Mission
To be a leading company dedicated to providing significant added values for the benefit of our customers, business partners and stakeholders through effective, efficient, and continuous operations to achieve “health for all” nationwide, as well as regionally and globally.
To establish our pharmaceutical capacities and competencies in enhancing the quality of our healthcare system through:
- Innovation and continuous improvement
- Increasing our market
- Cost leadership
- Establishing strategic alliances
All team members at Dexa Group are expected to:
A commitment to provide the best possible value to our customers
An emphasis on honesty and integrity
An effort to always understand and respect one another
Operationally, Dexa Group prioritizes four key areas:
These priorities have helped Dexa consistently outperform the Indonesian pharmaceutical industry for over fifty-three years. In view of the burgeoning demand for its products, Dexa Group has redoubled its research, manufacturing, and marketing capabilities. Today, it comprises four renowned companies: